Vancouver, British Columbia, March 28, 2022 / Globe Newswire / – Wellbeing Digital Sciences Inc.  (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based  healthcare company focused on innovative clinical solutions, artificial intelligence-powered digital  therapeutics and contract research, today announced that it has granted 5,099,999 compensation stock  options (the “Options”) and 3,000,000 restricted share units (the “RSUs”) to certain directors, officers,  employees, advisors, and consultants of the Company. The Options shall vest immediately and be  exercisable into common shares at a price of $0.215 per Option for a period of 5 years from issuance. The  RSUs are subject to future vesting with one quarter vesting at each of 3, 6, 9, and 12 months from the date  of issuance and shall be exercisable for 24 months. The Options and RSUs are issued as part of its  compensation programs to incentivize and retain its board of directors, executives, and managers.  

Additionally, the Company announced that it has cancelled 2,975,000 incentive stock options (the  "Cancelled Options") and 5,000,000 RSUs pursuant to the terms of its stock option plan and restricted  share unit plan, respectively. The Cancelled Options had been granted between March 22, 2021 and July 5,  2021 to several consultants of the Company and were voluntarily surrendered by the holders for no  consideration.  


Wellbeing Digital Sciences Inc. is an evidence-based healthcare company focused on innovative clinical  solutions, artificial intelligence-powered digital therapeutics and contract research. Its mission is supported  by a network of North American clinics that provide ketamine-assisted therapies and other types of  treatment to patients as well as through a contract research organization that offers clinical trials services  to clients pursuing drug development. In essence, the company exists to make breakthrough treatments  more accessible and to offer patients transformational experiences.  

On behalf of:  


"Adam Deffett"  

Adam Deffett, Interim CEO  

For further information, please contact: 

Nick Kuzyk, Investor Relations  

Tel: 1-844-746-6351  



Twitter: @Wellbeing_IR  

Notice Regarding Forward-Looking Information: 

This news release contains forward-looking statements including but not limited to statements regarding  the Company’s business, assets or investments, as well other statements that are not historical facts. Readers  are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that  the plans, intentions or expectations upon which they are based will occur. By their nature, forward-looking  statements involve numerous assumptions, known and unknown risks and uncertainties, both general and  specific, that contribute to the possibility that the predictions, forecasts, projections and other forward 

looking statements will not occur, which may cause actual performance and results in future periods to  differ materially from any estimates or projections of future performance or results expressed or implied by  such forward-looking statements. These assumptions, risks and uncertainties include, among other things,  the state of the economy in general and capital markets in particular, investor interest in the business and  prospects of the Company.  

The forward-looking statements contained in this news release are made as of the date of this news release.  Except as required by law, the Company disclaims any intention and assumes no obligation to update or  revise any forward-looking statements, whether as a result of new information, future events or otherwise,  except as required by applicable securities law. Additionally, the Company undertakes no obligation to  comment on the expectations of, or statements made, by third parties in respect of the matters discussed  above.